Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathy Pan

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
The Lancet. Oncology|November 22, 2017
Complexity of intermittent letrozole adjuvant therapyRowan T Chlebowski, Kathy Pan
Clinical Breast Cancer|February 8, 2014
Adjuvant endocrine therapy of perimenopausal and recently postmenopausal women with hormone receptor-positive breast cancerKathy Pan, Rowan T Chlebowski
The New England Journal of Medicine|October 26, 2018
Adjuvant Endocrine Therapy for Premenopausal Breast CancerRowan T Chlebowski, Kathy Pan
The New England Journal of Medicine|October 2, 2014
Exemestane with ovarian suppression in premenopausal breast cancerRowan T Chlebowski, Kathy Pan
Breast Cancer Research and Treatment|January 15, 2018
Breast cancer survivorship: state of the scienceKathy Pan, Arti Hurria, Rowan T Chlebowski
Breast Cancer Research and Treatment|March 30, 2017
ResponseRowan T Chlebowski, Kathy Pan, F Nananda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2019
Reply to F. Conforti et alKathy Pan, Linda Bosserman, Rowan T Chlebowski
Breast Cancer Research and Treatment|October 28, 2016
Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancerRowan T Chlebowski, Kathy Pan, Nananda F Col
Targeted Oncology|May 10, 2019
Current Systemic Treatment Landscape of Advanced Gynecologic MalignanciesKathy Pan, Jun Gong, Karen Huynh, et al.
JCO Oncology Practice|March 21, 2022
Breast Cancer Prevention and Breast Cancer MortalityRowan T Chlebowski, Aaron K Aragaki, Kathy Pan
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
The Lancet. Oncology|November 22, 2017
Complexity of intermittent letrozole adjuvant therapyRowan T Chlebowski, Kathy Pan
Clinical Breast Cancer|February 8, 2014
Adjuvant endocrine therapy of perimenopausal and recently postmenopausal women with hormone receptor-positive breast cancerKathy Pan, Rowan T Chlebowski
The New England Journal of Medicine|October 26, 2018
Adjuvant Endocrine Therapy for Premenopausal Breast CancerRowan T Chlebowski, Kathy Pan
The New England Journal of Medicine|October 2, 2014
Exemestane with ovarian suppression in premenopausal breast cancerRowan T Chlebowski, Kathy Pan
Breast Cancer Research and Treatment|January 15, 2018
Breast cancer survivorship: state of the scienceKathy Pan, Arti Hurria, Rowan T Chlebowski
Breast Cancer Research and Treatment|March 30, 2017
ResponseRowan T Chlebowski, Kathy Pan, F Nananda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2019
Reply to F. Conforti et alKathy Pan, Linda Bosserman, Rowan T Chlebowski
Breast Cancer Research and Treatment|October 28, 2016
Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancerRowan T Chlebowski, Kathy Pan, Nananda F Col
Targeted Oncology|May 10, 2019
Current Systemic Treatment Landscape of Advanced Gynecologic MalignanciesKathy Pan, Jun Gong, Karen Huynh, et al.
JCO Oncology Practice|March 21, 2022
Breast Cancer Prevention and Breast Cancer MortalityRowan T Chlebowski, Aaron K Aragaki, Kathy Pan
Pageof 8